Bioventus Inc.
BVS
$6.55
$0.121.87%
NASDAQ
| 03/29/2025 | 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.64M | -156.00K | -4.82M | -23.99M | -4.89M |
| Total Depreciation and Amortization | 11.87M | -18.01M | 12.28M | 13.09M | 11.79M |
| Total Amortization of Deferred Charges | -- | 5.58M | -- | -- | -- |
| Total Other Non-Cash Items | 2.64M | 34.02M | 3.32M | 20.52M | 1.86M |
| Change in Net Operating Assets | -31.20M | -2.11M | -458.00K | 5.54M | -14.76M |
| Cash from Operations | -19.33M | 19.32M | 10.32M | 15.16M | -6.01M |
| Capital Expenditure | -826.00K | -574.00K | -64.00K | -77.00K | -291.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | 24.68M | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | -709.00K |
| Cash from Investing | -826.00K | 24.10M | -64.00K | -77.00K | -1.00M |
| Total Debt Issued | 15.00M | -- | -- | -- | -- |
| Total Debt Repaid | -5.00M | -48.26M | 0.00 | -8.26M | -3.06M |
| Issuance of Common Stock | 150.00K | 1.10M | 553.00K | 609.00K | 177.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.20M | 4.31M | -191.00K | -190.00K | -1.36M |
| Cash from Financing | 947.00K | -42.86M | 362.00K | -7.85M | -4.24M |
| Foreign Exchange rate Adjustments | 430.00K | -2.06M | 466.00K | -419.00K | -544.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.78M | -1.49M | 11.08M | 6.82M | -11.79M |